If it involves the heart, the valves, the aorta, or the coronary arteries — we review it. Our Heart Team covers the full spectrum of cardiovascular surgical decision-making.
Each category includes full risk stratification, guideline mapping, and treatment alternative analysis.
Aortic stenosis, aortic regurgitation, bicuspid aortic valve
TAVR vs SAVR decision support with STS-PROM and TVT Registry risk benchmarking. Ross procedure candidacy assessment.
Mitral regurgitation, mitral stenosis, mitral valve prolapse
Repair vs replacement analysis with surgeon-specific repair rates. MitraClip candidacy. Barlow's disease complexity scoring.
Multi-vessel CAD, left main disease, prior PCI failure
CABG vs PCI decision framework with SYNTAX scoring. Completeness of revascularization analysis. Hybrid approach evaluation.
Ascending, arch, descending, thoracoabdominal
Open vs endovascular approach assessment. Acute vs chronic dissection management. Marfan and connective tissue disorder considerations.
Advanced HF, cardiomyopathy, ventricular dysfunction
LVAD candidacy evaluation. Transplant listing assessment. Optimal medical therapy review. Destination vs bridge-to-transplant strategy.
Surgical ablation, standalone ablation, LAA management
Maze procedure candidacy. Left atrial appendage management strategy concurrent with cardiac surgery. Hybrid ablation evaluation.
Native and prosthetic valve endocarditis. Timing of surgery, vegetation management, antibiotic therapy coordination.
Septal myectomy vs alcohol septal ablation. LVOT obstruction assessment. SCD risk stratification.
Repeat sternotomy risk assessment. Alternative access strategies. Prior operative report and imaging analysis.
Constrictive pericarditis evaluation. Pericardiectomy candidacy. Recurrent pericardial effusion management.
Complex congenital repairs. Fontan revision. Grown-up congenital heart disease (GUCH) surgical planning.
Combined aortic and mitral pathology. Triple valve disease. Staged vs simultaneous repair strategies.
Myxoma, papillary fibroelastoma, malignant cardiac tumors. Surgical approach and timing.
Paravalvular leak, prosthetic valve dysfunction, sternal wound complications, graft patency evaluation.
Our Heart Team reviews all cardiovascular surgical conditions. Contact us to discuss your specific case.